185 related articles for article (PubMed ID: 32871871)
1. Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.
Guan H; Xia MD; Wang M; Guan YJ; Lyu XC
Medicine (Baltimore); 2020 Aug; 99(35):e21558. PubMed ID: 32871871
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and susceptibility to diabetic nephropathy in Chinese type 2 diabetic patients: a meta-analysis.
Chang WW; Zhang L; Yao YS; Su H; Jin YL; Chen Y
Ren Fail; 2013 Aug; 35(7):1038-43. PubMed ID: 23822721
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.
Zhou TB; Drummen GP; Jiang ZP; Li HY
Ren Fail; 2015; 37(8):1247-59. PubMed ID: 26161693
[TBL] [Abstract][Full Text] [Related]
4. Interaction of MTHFR C677T polymorphism with smoking in susceptibility to diabetic nephropathy in Chinese men with type 2 diabetes.
Ma L; Jiang Y; Kong X; Liu Q; Zhao H; Zhao T; Cao Y; Li P
J Hum Genet; 2019 Jan; 64(1):23-28. PubMed ID: 30397262
[TBL] [Abstract][Full Text] [Related]
5. Is C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabetic nephropathy or diabetes mellitus in a Chinese population?
Cui WP; Du B; Jia Y; Zhou WH; Liu SM; Cui YC; Ma FZ; Luo P; Miao LN
Arch Med Res; 2012 Jan; 43(1):42-50. PubMed ID: 22209973
[TBL] [Abstract][Full Text] [Related]
6. MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: a meta-analysis.
Yang S; Zhang J; Feng C; Huang G
Metabolism; 2013 Apr; 62(4):586-94. PubMed ID: 23174406
[TBL] [Abstract][Full Text] [Related]
7. Association between MTHFR C677T polymorphism and diabetic nephropathy in the Chinese population: An updated meta-analysis and review.
Xiong X; Lin XK; Xiao X; Qin DP; Zhou DY; Hu JG; Liu Y; Zhong XS
Nephrology (Carlton); 2016 Jan; 21(1):5-12. PubMed ID: 26072975
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of MTHFR C677T with preterm birth and low birth weight susceptibility: a meta-analysis.
Wu H; Zhu P; Geng X; Liu Z; Cui L; Gao Z; Jiang B; Yang L
Arch Gynecol Obstet; 2017 May; 295(5):1105-1118. PubMed ID: 28283826
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the relationship between methylenetetrahydrofolate reductase C677T and A1298C polymorphism and venous thromboembolism in the Caucasian and Asian.
Gao M; Feng N; Zhang M; Ti X; Zuo X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32614041
[TBL] [Abstract][Full Text] [Related]
10. Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility.
Meng Y; Liu X; Ma K; Zhang L; Lu M; Zhao M; Guan MX; Qin G
Mol Genet Genomic Med; 2019 Dec; 7(12):e1020. PubMed ID: 31663297
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients.
Sun J; Xu Y; Zhu Y; Lu H
Diabetes Res Clin Pract; 2004 Jun; 64(3):185-90. PubMed ID: 15126006
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies.
Zhu B; Wu X; Zhi X; Liu L; Zheng Q; Sun G
PLoS One; 2014; 9(7):e102443. PubMed ID: 25047451
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the relationship between MTHFR gene A1298C polymorphism and the risk of adult stroke.
Zhang MJ; Hu ZC; Yin YW; Li BH; Liu Y; Liao SQ; Gao CY; Li JC; Zhang LL
Cerebrovasc Dis; 2014; 38(6):425-32. PubMed ID: 25472665
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy].
Wang L; Wang J; Xue Y; Chen Y; Zou H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):276-8. PubMed ID: 11484165
[TBL] [Abstract][Full Text] [Related]
15. Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.
Wu YL; Yang HY; Ding XX; Zhao X; Chen J; Bi P; Sun YH
Seizure; 2014 Jun; 23(6):411-6. PubMed ID: 24556013
[TBL] [Abstract][Full Text] [Related]
16. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies.
Tang M; Wang SQ; Liu BJ; Cao Q; Li BJ; Li PC; Li YF; Qin C; Zhang W
Mol Biol Rep; 2014 Jul; 41(7):4659-73. PubMed ID: 24744129
[TBL] [Abstract][Full Text] [Related]
17. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis.
Wang B; Ma M; Guo X; Yan Y; Li L
Medicine (Baltimore); 2021 Oct; 100(41):e27527. PubMed ID: 34731145
[TBL] [Abstract][Full Text] [Related]
18. Association between end-stage diabetic nephropathy and MTHFR (C677T and A1298C) gene polymorphisms.
Ramanathan G; Harichandana B; Kannan S; Elumalai R; Sfd P
Nephrology (Carlton); 2019 Feb; 24(2):155-159. PubMed ID: 29227003
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus.
Rahimi M; Hasanvand A; Rahimi Z; Vaisi-Raygani A; Mozafari H; Rezaei M; Zargooshi J; Najafi F; Shakiba E
Clin Biochem; 2010 Nov; 43(16-17):1333-9. PubMed ID: 20800057
[TBL] [Abstract][Full Text] [Related]
20. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA
J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
